Neurological Sciences

, Volume 32, Issue 6, pp 1233–1238 | Cite as

Dementia in life writing: our health care system in the words of the sufferer

  • Martina Zimmermann
Healthcare Organization


Alzheimer’s disease as the most common neurodegenerative disorder places enormous financial demands on our society that is increasingly focussed on the cost-effectiveness of treatment and care. The present article reflects on central information drawn from four autobiographical texts written by patients in the early stage of dementia, elucidating their needs relating to, first, the medication they rely on and, second, the importance of a healthy doctor–patient relationship. Their comments and feelings are placed in the context of clinical practice and current health care policy pertaining to our dealing with dementia, thus, contributing to ongoing discussions relating to the suitability of current health care structures in view of challenging demographic changes.


Alzheimer’s disease Dementia Life writing Cost-effectiveness Quality of care 



The author is grateful to J. Klein for welcoming interdisciplinary approaches and to S.P. Brown for continuous discussion and encouragement. The study was entirely self-funded and there is no conflict of interest to be declared.


  1. 1.
    Michel JP, Zekry D, Mulligan R, Giacobini E, Gold G (2001) Economic considerations of Alzheimer’s disease and related disorders. Aging 13(3):255–260PubMedGoogle Scholar
  2. 2.
    Cotter VT (2006) Alzheimer’s disease: issues and challenges in primary care. Nurs Clin North Am 41(1):83–93 viPubMedCrossRefGoogle Scholar
  3. 3.
    Schmid HJ (2001) Walter Matthias Diggelmann––the healing effect of story telling. Praxis 90(25–26):1148–1150PubMedGoogle Scholar
  4. 4.
    Frank AW (1995) The Wounded Storyteller. Body, illness and ethics. University of Chicago Press, ChicagoGoogle Scholar
  5. 5.
    Kleinman A (1988) The illness narratives. Suffering, healing and the human condition. Basic Books, New YorkGoogle Scholar
  6. 6.
    Maudsley G, Williams EM, Taylor DC (2007) Junior medical students’ notions of a ‘good doctor’ and related expectations: a mixed methods study. Med Educ 41(5):476–486PubMedCrossRefGoogle Scholar
  7. 7.
    Klein ER (2005) Effective communication with patients. Pa Nurse 60(4):14–15PubMedCrossRefGoogle Scholar
  8. 8.
    Centor RM (2007) Seek first to understand. Philos Ethics Humanit Med 2:29PubMedCrossRefGoogle Scholar
  9. 9.
    Graboys T (2008) Life in the Balance. A physician’s memoir of life, love and loss with Parkinson’s disease and dementia. Union Square Press, New YorkGoogle Scholar
  10. 10.
    DeBaggio T (2002) Losing my mind. An intimate look at life with Alzheimer’s. The Free Press, New YorkGoogle Scholar
  11. 11.
    Couturier C (2004) Puzzle, Journal d’une Alzheimer. Éditions Josette Lyon, ParisGoogle Scholar
  12. 12.
    Lee J (2003) Just love me. My life turned upside-down by Alzheimer’s. Purdue University Press, West LafayetteGoogle Scholar
  13. 13.
    Hanson JC, Lippa CF (2009) Lewy body dementia. Int Rev Neurobiol 84:215–228PubMedCrossRefGoogle Scholar
  14. 14.
    Robottom BJ, Weiner WJ (2009) Dementia in Parkinson’s disease. Int Rev Neurobiol 84:229–244PubMedCrossRefGoogle Scholar
  15. 15.
    Garrard P, Maloney LM, Hodges JR, Patterson K (2005) The effects of very early Alzheimer’s disease on the characteristics of writing by a renowned author. Brain 128(Pt 2):250–260PubMedGoogle Scholar
  16. 16.
    Irigaray L (1973) Le langage des déments. Mouton, The HagueGoogle Scholar
  17. 17.
    Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosurg Psychiatry 66(2):137–147PubMedCrossRefGoogle Scholar
  18. 18.
    Zimmermann M, Gardoni F, Di Luca M (2005) Molecular rationale for the pharmacological treatment of Alzheimer’s disease. Drugs Aging 22(Suppl 1):27–37PubMedCrossRefGoogle Scholar
  19. 19.
    Ringman JM, Cummings JL (2006) Current and emerging pharmacological treatment options for dementia. Behav Neurol 17(1):5–16PubMedGoogle Scholar
  20. 20.
    Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E et al (2004) Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trial. Lancet 363(9427):2105–2115PubMedCrossRefGoogle Scholar
  21. 21.
    Weinmann S, Roll S, Schwarzbach C, Vauth C, Willich SN (2010) Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr 10(1):14PubMedCrossRefGoogle Scholar
  22. 22.
    Zimmermann M, Colciaghi F, Cattabeni F, Di Luca M (2002) Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer’s disease. Cell Mol Biol (Noisy -le-grand) 48(6):613–623Google Scholar
  23. 23.
    Pratico D (2008) Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows. Ann N Y Acad Sci 1147:70–78PubMedCrossRefGoogle Scholar
  24. 24.
    Trabucchi M (1999) An economic perspective on Alzheimer’s disease. J Geriatr Psychiatry Neurol 12(1):29–38PubMedCrossRefGoogle Scholar
  25. 25.
    Wimo A (2007) Clinical and economic outcomes–friend or foe? Int Psychogeriatr 19(3):497–507PubMedCrossRefGoogle Scholar
  26. 26.
    Fillit H, Hill J (2005) Economics of dementia and pharmacoeconomics of dementia therapy. Am J Geriatr Pharmacother 3(1):39–49PubMedCrossRefGoogle Scholar
  27. 27.
    Broyard A (1992) Intoxicated by my illness. Fawcett Columbine, New YorkGoogle Scholar
  28. 28.
    Hunsacker Hawkins A (1999) Reconstructing illness. Studies in pathography, 2nd edn. Purdue University Press, West LafayetteGoogle Scholar
  29. 29.
    Sweeney B (1998) James Mackenzie Lecture 1997. The place of the humanities in the education of a doctor. Br J Gen Pract 48(427):998–1002PubMedGoogle Scholar
  30. 30.
    Hurwitz B, Vickers N (2006) King’s dialogues: literature and medicine introduction. Lit Med 25(2 (Fall 2006)):189–193Google Scholar
  31. 31.
    Calman KC, Downie RS, Duthie M, Sweeney B (1988) Literature and medicine: a short course for medical students. Med Educ 22(4):265–269PubMedCrossRefGoogle Scholar
  32. 32.
    Downie RS, Hendry RA, Macnaughton RJ, Smith BH (1997) Humanizing medicine: a special study module. Med Educ 31(4):276–280PubMedCrossRefGoogle Scholar
  33. 33.
    Charon R (2006) Narrative medicine. Honouring the stories of illness. Oxford University Press, New YorkGoogle Scholar
  34. 34.
    Montogmery Hunter K (1991) Doctors’ stories. The narrative structure of medical knowledge. Princeton University Press, PrincetonGoogle Scholar
  35. 35.
    Stanley P (2004) The patient’s voice: a cry in solitude or a call for community. Lit Med 23(2):346–363PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Department of Pharmacology, School of PharmacyGoethe UniversityFrankfurt am MainGermany

Personalised recommendations